Kellogg School

CIRI Announces 2024 Annual General Meeting Voting Results

Retrieved on: 
星期三, 六月 12, 2024

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- The Canadian Investor Relations Institute (CIRI) is pleased to report that, at its Annual Meeting of Shareholders held on June 3, 2024, 13 nominees were elected as Directors.

Key Points: 
  • TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- The Canadian Investor Relations Institute (CIRI) is pleased to report that, at its Annual Meeting of Shareholders held on June 3, 2024, 13 nominees were elected as Directors.
  • “It gives me great pleasure to announce that three accomplished individuals – Bruno, Mahsa and Ann – will be joining the CIRI Board.
  • They bring extensive investor relations and capital markets expertise that will be an asset to the organization as we work together to advance the investor relations profession,” commented Adam Borgatti, Chair, CIRI Board.
  • The following individuals will serve as Directors of CIRI:
    Senior Vice President, Corporate Development & Investor Relations, Aecon Group Inc.

Milk Specialties Global Appoints Dan Nisser, Seasoned Ingredients Finance Executive, as Chief Financial Officer

Retrieved on: 
星期三, 六月 12, 2024

Milk Specialties Global (“MSG”), a leading nutritional ingredients manufacturer, today announced the appointment of Dan Nisser as Chief Financial Officer.

Key Points: 
  • Milk Specialties Global (“MSG”), a leading nutritional ingredients manufacturer, today announced the appointment of Dan Nisser as Chief Financial Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240612102245/en/
    Mr. Nisser brings more than 30 years of progressive experience in finance and operations management within global multi-billion-dollar organizations to MSG.
  • “Dan is a proven senior finance executive in the ingredients space who has built an impressive track record over the past three decades in supporting profitable growth at multinational food companies," said David Lenzmeier, Chief Executive Officer at MSG.
  • “On behalf of the entire team at MSG, we are thrilled to welcome Dan to the leadership team.

CoastEdge Partners Reunites with Nancy Vo Hamada as New Partner and COO

Retrieved on: 
星期四, 六月 6, 2024

CoastEdge Partners, LLC , a Registered Investment Advisor headquartered in San Diego, CA, is delighted to announce the hiring of Nancy Vo Hamada as Partner and Chief Operating Officer (COO).

Key Points: 
  • CoastEdge Partners, LLC , a Registered Investment Advisor headquartered in San Diego, CA, is delighted to announce the hiring of Nancy Vo Hamada as Partner and Chief Operating Officer (COO).
  • Vo Hamada’s arrival at CoastEdge signifies a special reunion, as managing partner Steve Simpson previously collaborated with Vo Hamada for over a decade at Gurtin Municipal Bond Management, a firm that Simpson co-founded.
  • CoastEdge Partners was a very early adopter of Addepar technology given their deep expertise in the management of institutional alternative investments for clients alongside the firm’s managing partners.
  • “We are excited for Nancy to join CoastEdge Partners and contribute to its continued growth and success," said Rich Effress, Managing Partner.

Phillip Enochs Joins Duff & Phelps Investment Management As Global Head of Business Development

Retrieved on: 
星期四, 五月 23, 2024

Duff & Phelps Investment Management Co. today announced that Phillip Enochs, CFA, has joined the company as an executive managing director and global head of business development.

Key Points: 
  • Duff & Phelps Investment Management Co. today announced that Phillip Enochs, CFA, has joined the company as an executive managing director and global head of business development.
  • Enochs, who also joins the firm’s Executive Committee, will be responsible for institutional distribution strategies, business development, marketing, and client service for the firm, which had $12.2 billion of assets under management as of March 31, 2024.
  • He reports to David D. Grumhaus, Jr., president and chief investment officer of Duff & Phelps.
  • Previously, he was responsible for sales, service, and marketing for the U.S. institutional and intermediary channels at BMO Global Asset Management.

Alto Neuroscience Appoints Michael Hanley as Chief Operating Officer

Retrieved on: 
星期二, 五月 21, 2024

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the expansion of the Company’s leadership team with the addition of industry veteran Michael Hanley as chief operating officer (COO).

Key Points: 
  • Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the expansion of the Company’s leadership team with the addition of industry veteran Michael Hanley as chief operating officer (COO).
  • Mr. Hanley brings over twenty-five years of leadership experience in the life sciences industry, with established expertise across corporate operations, product development, strategy, and commercialization, with relevant expertise in CNS/neuroscience-focused companies.
  • “Mike has dedicated his career to leading the product life cycle for companies in CNS and psychiatry, from early-stage planning and portfolio strategy through launch and brand management,” said Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto.
  • At Alto we aim to develop each of our programs based on sound scientific, strategic, and commercial considerations; we believe adding Mike to the team at this juncture will further our ability to do this across our broad pipeline.”
    Prior to joining Alto, Mr. Hanley served as chief commercial officer and chief business officer at Aeglea BioTherapeutics.

Visier's First Quarter of 2024 Marks Unprecedented Scale in Generative AI Production Use and Transformational Investment in Analytic Platform Capabilities

Retrieved on: 
星期二, 五月 14, 2024

VANCOUVER, BC, May 14, 2024 /PRNewswire/ -- Visier, the globally recognized leader in people analytics and workforce solutions for people-powered business, today announced highlights from its first quarter of the fiscal year, which ended on April 30, 2024.

Key Points: 
  • Unprecedented scale deployment of Visier's AI technology, " Vee for Partners ," to 2.1 million employees of Paycor customers.
  • "Vee is one of the most spectacular examples of generative AI in HR today," said Josh Bersin, globally recognized HR industry analyst.
  • HR professionals need to connect data to diagnose people and business problems, and tools like Vee make this amazingly easy."
  • Visier also drove a strong quarter for renewals, securing contracts with customers in financial services, retail, automotive and government.

Gupshup hires marketing leader Salim Ali as Chief Marketing Officer

Retrieved on: 
星期三, 五月 8, 2024

SAN FRANCISCO and MUMBAI, India, May 8, 2024 /PRNewswire/ -- Gupshup, the leading Conversation Cloud, announced the appointment of Salim Ali as Chief Marketing Officer (CMO).

Key Points: 
  • SAN FRANCISCO and MUMBAI, India, May 8, 2024 /PRNewswire/ -- Gupshup, the leading Conversation Cloud, announced the appointment of Salim Ali as Chief Marketing Officer (CMO).
  • Having led large and globally dispersed teams, Salim brings deep marketing experience, building and scaling business lines across large enterprises and startups.
  • In his previous role, Salim was the Chief Marketing Officer at WordPress VIP, where he was running all things marketing from amplifying the WordPress brand voice, product marketing, new demand to industry and customer marketing.
  • Salim Ali, Chief Marketing Officer, Gupshup said, "I'm thrilled to join Gupshup at this stage of global growth.

Dion Cornett Joins Tatum as Chief Executive Officer

Retrieved on: 
星期二, 五月 7, 2024

LONDON, May 7, 2024 /PRNewswire/ -- Tatum, a leading platform for blockchain application development, is thrilled to announce the appointment of Dion Cornett as its new Chief Executive Officer.

Key Points: 
  • LONDON, May 7, 2024 /PRNewswire/ -- Tatum, a leading platform for blockchain application development, is thrilled to announce the appointment of Dion Cornett as its new Chief Executive Officer.
  • Dion brings to Tatum two decades of experience in the software industry and an exceptional track record in successfully scaling businesses through product led growth.
  • Dion Cornett is recognized as an expert in open-source software and database technologies, having held senior leadership positions at Red Hat, MariaDB, ReachForce, Liquibase and DBeaver.
  • "I am excited to join Tatum and work with a talented team that is passionate about leveraging blockchain technology to redefine our digital future," said Dion Cornett.

Dion Cornett Joins Tatum as Chief Executive Officer

Retrieved on: 
星期二, 五月 7, 2024

LONDON, May 7, 2024 /PRNewswire/ -- Tatum, a leading platform for blockchain application development, is thrilled to announce the appointment of Dion Cornett as its new Chief Executive Officer.

Key Points: 
  • LONDON, May 7, 2024 /PRNewswire/ -- Tatum, a leading platform for blockchain application development, is thrilled to announce the appointment of Dion Cornett as its new Chief Executive Officer.
  • Dion brings to Tatum two decades of experience in the software industry and an exceptional track record in successfully scaling businesses through product led growth.
  • Dion Cornett is recognized as an expert in open-source software and database technologies, having held senior leadership positions at Red Hat, MariaDB, ReachForce, Liquibase and DBeaver.
  • "I am excited to join Tatum and work with a talented team that is passionate about leveraging blockchain technology to redefine our digital future," said Dion Cornett.

SFA Therapeutics Strengthens Management Team with Appointment of Chief Medical Officer

Retrieved on: 
星期四, 五月 2, 2024

JENKINTOWN, Pa., May 2, 2024 /PRNewswire/ -- SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory diseases, today announced the appointment of Stefan C. Weiss, MD, MBA, as Chief Medical Officer.

Key Points: 
  • JENKINTOWN, Pa., May 2, 2024 /PRNewswire/ -- SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory diseases, today announced the appointment of Stefan C. Weiss, MD, MBA, as Chief Medical Officer.
  • "Dr. Weiss brings decades of multi-faceted clinical and industry experience in both dermatology and immunology," commented Ira Spector, Ph.D., CEO of SFA Therapeutics.
  • "I am honored to join the SFA Therapeutics team to help shape the clinical pathway forward for SFA-002 and other candidates that target inflammatory disease.
  • As a practicing dermatologist, I have witnessed the immense need for novel therapeutics with greater efficacy and fewer side effects than the currently available treatments for chronic inflammatory skin conditions," stated Dr. Weiss, Chief Medical Officer of SFA Therapeutics.